These updates are republished press releases and communications from members of the Science|Business Network. Network Updates can be sent to [email protected] and [email protected]. To know if your content piece qualifies as Network Update, check the editorial guidelines here.

Investing: Cleantech takes the spotlight

With high oil prices showing no sign of quitting, "cleantech" is the new darling VC investment sector. But, asks Mary Lisbeth D'Amico, is the market more froth than substance?
01 Feb 2006

Biotech brings silver lining to pharma cloud

Last month the world's leading pharmaceutical company received simultaneous FDA approval for two new therapies. Yet neither drug was invented by the company. Both were originally developed by small biotechs.
01 Feb 2006